SkinHealth Systems Inc. SKIN
0.66
(0.02)
(2.94%)
as of 25 Sep
- Market cap
- $78.4M
- P/E
- 0.0×
Follow SKIN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (43.89%) | (11.95%) | (16.87%) | (18.73%) |
+8 more TTM periods Free account |
|
| (5.72%) | (1.06%) | (1.61%) | (1.95%) | ||
ROIC |
(1.38%) | (3.39%) | (6.74%) | (8.38%) | |
Return on Tangible Assets |
(22.02%) | (4.85%) | (7.57%) | (4.71%) | |
Average Days of Receivables |
24.71 | 24.96 | 28.44 | 30.70 | |
Free Cash Flow per Share |
0.13 | 0.18 | 0.26 | 0.27 | |
Free Cash Flow |
16.64 | 23.27 | 32.32 | 34.12 | |
Capital Expenditures |
(5.32) | (5.67) | (5.16) | (4.64) | |
Piotroski F-Score |
5.00 | 6.00 | 6.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
3.62% | 4.79% | 5.70% | 5.98% | |
Accounts Receivable Turnover |
12.41 | 13.53 | 11.59 | 9.73 | |
Accounts Payable Turnover |
5.00 | 5.32 | 5.56 | 5.26 | |
Inventory Turnover |
1.84 | 1.83 | 1.78 | 1.64 | |
Average Days of Payables |
60.03 | 55.81 | 54.64 | 59.41 | |
Days of Inventory on Hand |
175.18 | 167.55 | 167.82 | 192.89 | |
Tax Rate |
0.20 | 0.71 | 0.60 | (0.09) | |
Research and Development Expense of Revenue |
2.03% | 1.94% | 1.87% | 1.71% | |
Selling, General and Administrative Expense of Revenue |
65.81% | 66.55% | 70.33% | 72.41% | |
Share Based Compensation of Revenue |
3.80% | 4.53% | 4.93% | 5.66% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.77) | (4.78) | (3.94) | (3.30) | |
Depreciation/Fixed assets |
13.60 | 12.15 | 11.42 | 9.81 | |
Capex/Depreciation |
(0.19) | (0.20) | (0.18) | (0.15) | |
Revenue per Share |
2.24 | 2.32 | 2.38 | 2.38 | |
Operating CF per Share |
0.17 | 0.23 | 0.30 | 0.31 | |
Capex per Share |
(0.04) | (0.04) | (0.04) | (0.04) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
(9.80%) | (2.04%) | (3.16%) | (3.89%) |
Columns are period end dates